NCT03592407 2022-03-08
Epacadostat and Pembrolizumab Before Surgery in Treating Participants With Stage II-III Esophageal or Gastroesophageal Cancer
City of Hope Medical Center
Phase 2 Withdrawn
City of Hope Medical Center
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
M.D. Anderson Cancer Center
University of Chicago
City of Hope Medical Center
University of Chicago